Global Personalized Ophthalmology Therapies Market Report 2025

Item added to cart!

Published : December 2025

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Personalized Ophthalmology Therapies Global Market Report 2025

Name: Personalized Ophthalmology Therapies Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Therapy Type (Gene Therapy, Cell Therapy, Pharmacogenomics, Targeted Drug Delivery, Other Therapy Types); By Indication (Age-Related Macular Degeneration, Diabetic Retinopathy, Glaucoma, Retinitis Pigmentosa, Other Indications); By End User (Hospitals, Specialty Clinics, Research Institutes, Other End Users); Subsegments:; By Gene Therapy (Viral Vector-Based Gene Therapy, Non-Viral Gene Therapy, CRISPR Or Cas9-Based Gene Editing); By Cell Therapy (Stem Cell Therapy, Retinal Pigment Epithelial (RPE) Cell Therapy); By Pharmacogenomics (Drug Response Testing, Personalized Drug Dosing); By Targeted Drug Delivery (Nanoparticle-Based Delivery); By Other Therapy Types (Peptide-Based Therapy) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Personalized Ophthalmology Therapies Market Overview

• Personalized Ophthalmology Therapies market size has reached to $2.82 billion in 2024

• Expected to grow to $5.46 billion in 2029 at a compound annual growth rate (CAGR) of 14%

• Growth Driver: Rising Prevalence Of Chronic Vision Disorders Driving The Growth Of The Market Due To Increasing Diabetes Cases And Associated Eye Complications

• Market Trend: Advancements In Single-Dose Intravitreal Gene Therapies Reducing Treatment Burden And Enhancing Long-Term Efficacy

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Personalized Ophthalmology Therapies Market?

Personalized ophthalmology therapies refer to customized treatment approaches for eye diseases and vision disorders that are tailored to an individual patient’s unique genetic profile, molecular characteristics, lifestyle, and clinical condition. These therapies leverage advances in genomics, biomarker analysis, imaging, and precision medicine to optimize drug selection, dosage, or surgical intervention for conditions such as age-related macular degeneration (AMD), glaucoma, diabetic retinopathy, and inherited retinal diseases.

The main types of personalized ophthalmology therapies include gene therapy, cell therapy, pharmacogenomics, targeted drug delivery, and others. Gene therapy in ophthalmology involves introducing or altering genetic material within a patient's cells to treat eye diseases caused by genetic mutations. It is used for various indications such as age-related macular degeneration, diabetic retinopathy, glaucoma, retinitis pigmentosa, and others by several end users, including hospitals, specialty clinics, research institutes, and others.

Personalized Ophthalmology Therapies Market Size and growth rate 2025 to 2029: Graph

What Is The Personalized Ophthalmology Therapies Market Size 2025 And Growth Rate?

What Is The Personalized Ophthalmology Therapies Market Growth Forecast?

The personalized ophthalmology therapies market size is expected to see rapid growth in the next few years. It will grow to $5.46 billion in 2029 at a compound annual growth rate (CAGR) of 14.0%. The growth in the forecast period can be attributed to increasing accessibility of genetic testing and molecular diagnostics, surge in cases of age-related macular degeneration, rising awareness of personalized medicine, increasing healthcare expenditure, and increasing investment in ophthalmic research. Major trends in the forecast period include strategic collaborations between biotechnology firms, research institutes, and healthcare providers, deployment of artificial intelligence and machine learning in ophthalmology, integration of genomics and digital health technologies, rapid advancements in genetic and cellular therapies, and integration of advanced technologies.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How the Personalized Ophthalmology Therapies Market Segmented?

1) By Therapy Type: Gene Therapy, Cell Therapy, Pharmacogenomics, Targeted Drug Delivery, Other Therapy Types

2) By Indication: Age-Related Macular Degeneration, Diabetic Retinopathy, Glaucoma, Retinitis Pigmentosa, Other Indications

3) By End User: Hospitals, Specialty Clinics, Research Institutes, Other End Users

Subsegments:

1) By Gene Therapy: Viral Vector-Based Gene Therapy, Non-Viral Gene Therapy, CRISPR Or Cas9-Based Gene Editing

2) By Cell Therapy: Stem Cell Therapy, Retinal Pigment Epithelial (RPE) Cell Therapy, Induced Pluripotent Stem Cell (iPSC) Therapy

3) By Pharmacogenomics: Drug Response Testing, Genetic Biomarker-Based Therapy, Personalized Drug Dosing

4) By Targeted Drug Delivery: Nanoparticle-Based Delivery, Liposomal Drug Delivery, Hydrogel-Based Delivery Systems

5) By Other Therapy Types: RNA-Based Therapy, Antisense Oligonucleotide Therapy, Peptide-Based Therapy

What Is Driving The Personalized Ophthalmology Therapies Market? Rising Prevalence Of Chronic Vision Disorders Driving The Growth Of The Market Due To Increasing Diabetes Cases And Associated Eye Complications

The growing prevalence of chronic vision disorders is expected to propel the growth of the personalized ophthalmology therapies market going forward. Chronic vision disorders are persistent eye diseases that progressively impair vision and often require ongoing management over an extended period. Chronic vision disorders are rising due to the increasing prevalence of diabetes worldwide, which leads to complications such as diabetic retinopathy that progressively damage the eyes over time. Personalized ophthalmology therapies benefit chronic vision disorders by creating treatment plans tailored to an individual’s unique genetic and molecular profile, which enhances treatment effectiveness and helps slow the progression of the disease. For instance, in May 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based government agency, if effective measures are not implemented, cases of diabetic retinopathy are projected to rise by 72%, while cataract cases are expected to grow by 87% by 2050. Therefore, the growing prevalence of chronic vision disorders is driving the growth of the personalized ophthalmology therapies industry.

Who Are The Major Players In The Global Personalized Ophthalmology Therapies Market?

Major companies operating in the personalized ophthalmology therapies market are Roche Holding AG, Novartis AG, Regeneron Pharmaceuticals Inc., Alcon Inc., Genentech Inc., Bausch + Lomb Corporation, Johnson & Johnson Vision Care Inc., Carl Zeiss Meditec AG, Santen Pharmaceutical Co. Ltd., Ocular Therapeutix Inc., EyePoint Pharmaceuticals Inc., Senju Pharmaceutical Co. Ltd., MeiraGTx Ltd., Beacon Therapeutics, Clearside Biomedical Inc., Adverum Biotechnologies Inc., Ocugen Inc., GenSight Biologics, Nanoscope Therapeutics Inc., 4D Molecular Therapeutics Inc., Coave Therapeutics.

What Are The Key Trends Of The Global Personalized Ophthalmology Therapies Market? Advancements In Single-Dose Intravitreal Gene Therapies Reducing Treatment Burden And Enhancing Long-Term Efficacy

Major companies operating in the personalized ophthalmology therapies market are focusing on developing advanced solutions, such as one-time intravitreal gene therapies, to minimize patient burden and lower the risk of complications associated with multiple injections. One-time intravitreal gene therapies involve a single injection into the eye’s vitreous cavity to deliver genetic material that addresses or modifies underlying eye disorders, offering lasting treatment effects. For instance, in July 2025, Sanofi, a France-based pharmaceutical and healthcare company, announced the US Food and Drug Administration (FDA) has approved fast track designation for SAR446597. It is a single-dose intravitreal gene therapy designed to treat geographic atrophy (GA) caused by age-related macular degeneration (AMD). It has received fast-track designation to speed up development and regulatory review for serious conditions with unmet needs. The therapy introduces genetic material encoding two antibody fragments that block C1s in the classical complement pathway and factor Bb in the alternative pathway. This dual-action mechanism aims to provide long-lasting complement suppression in the retina, targeting the disease process while minimizing the need for repeated injections.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Personalized Ophthalmology Therapies Market? Datapharm Ltd. Acquired Original Digital Limited To Enhance Digital Medicines Information Access

In June 2022, Novartis AG, a Switzerland-based pharmaceutical company, acquired Kedalion Therapeutics for an undisclosed amount. Through the acquisition of Kedalion Therapeutics, Novartis gains access to advanced technologies that enable more precise delivery of ocular therapies, enhancing patient comfort during treatment. This strategic move emphasizes the company’s dedication to developing innovative, patient-focused solutions for various eye conditions. Kedalion Therapeutics is a US-based company specializing in personalized ophthalmology therapies.

What Is The Regional Outlook For The Global Personalized Ophthalmology Therapies Market?

North America was the largest region in the personalized ophthalmology therapies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Personalized Ophthalmology Therapies Market?

The personalized ophthalmology therapies market includes revenues earned by entities by providing services such as molecular profiling, biomarker identification, patient data integration services, and disease risk assessment. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Personalized Ophthalmology Therapies Industry?

The personalized ophthalmology therapies market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the personalized ophthalmology therapies industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

1. Executive Summary

2. Personalized Ophthalmology Therapies Market Characteristics

3. Personalized Ophthalmology Therapies Market Trends And Strategies

4. Personalized Ophthalmology Therapies Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Personalized Ophthalmology Therapies Growth Analysis And Strategic Analysis Framework

5.1. Global Personalized Ophthalmology Therapies PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Personalized Ophthalmology Therapies Market Growth Rate Analysis

5.4. Global Personalized Ophthalmology Therapies Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Personalized Ophthalmology Therapies Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Personalized Ophthalmology Therapies Total Addressable Market (TAM)

6. Personalized Ophthalmology Therapies Market Segmentation

6.1. Global Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Gene Therapy

Cell Therapy

Pharmacogenomics

Targeted Drug Delivery

Other Therapy Types

6.2. Global Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Age-Related Macular Degeneration

Diabetic Retinopathy

Glaucoma

Retinitis Pigmentosa

Other Indications

6.3. Global Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Specialty Clinics

Research Institutes

Other End Users

6.4. Global Personalized Ophthalmology Therapies Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Viral Vector-Based Gene Therapy

Non-Viral Gene Therapy

CRISPR Or Cas9-Based Gene Editing

6.5. Global Personalized Ophthalmology Therapies Market, Sub-Segmentation Of Cell Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Stem Cell Therapy

Retinal Pigment Epithelial (RPE) Cell Therapy

Induced Pluripotent Stem Cell (iPSC) Therapy

6.6. Global Personalized Ophthalmology Therapies Market, Sub-Segmentation Of Pharmacogenomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Drug Response Testing

Genetic Biomarker-Based Therapy

Personalized Drug Dosing

6.7. Global Personalized Ophthalmology Therapies Market, Sub-Segmentation Of Targeted Drug Delivery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Nanoparticle-Based Delivery

Liposomal Drug Delivery

Hydrogel-Based Delivery Systems

6.8. Global Personalized Ophthalmology Therapies Market, Sub-Segmentation Of Other Therapy Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

RNA-Based Therapy

Antisense Oligonucleotide Therapy

Peptide-Based Therapy

7. Personalized Ophthalmology Therapies Market Regional And Country Analysis

7.1. Global Personalized Ophthalmology Therapies Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Personalized Ophthalmology Therapies Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Personalized Ophthalmology Therapies Market

8.1. Asia-Pacific Personalized Ophthalmology Therapies Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Personalized Ophthalmology Therapies Market

9.1. China Personalized Ophthalmology Therapies Market Overview

9.2. China Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Personalized Ophthalmology Therapies Market

10.1. India Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Personalized Ophthalmology Therapies Market

11.1. Japan Personalized Ophthalmology Therapies Market Overview

11.2. Japan Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Personalized Ophthalmology Therapies Market

12.1. Australia Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Personalized Ophthalmology Therapies Market

13.1. Indonesia Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Personalized Ophthalmology Therapies Market

14.1. South Korea Personalized Ophthalmology Therapies Market Overview

14.2. South Korea Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Personalized Ophthalmology Therapies Market

15.1. Western Europe Personalized Ophthalmology Therapies Market Overview

15.2. Western Europe Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Personalized Ophthalmology Therapies Market

16.1. UK Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Personalized Ophthalmology Therapies Market

17.1. Germany Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Personalized Ophthalmology Therapies Market

18.1. France Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Personalized Ophthalmology Therapies Market

19.1. Italy Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Personalized Ophthalmology Therapies Market

20.1. Spain Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Personalized Ophthalmology Therapies Market

21.1. Eastern Europe Personalized Ophthalmology Therapies Market Overview

21.2. Eastern Europe Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Personalized Ophthalmology Therapies Market

22.1. Russia Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Personalized Ophthalmology Therapies Market

23.1. North America Personalized Ophthalmology Therapies Market Overview

23.2. North America Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Personalized Ophthalmology Therapies Market

24.1. USA Personalized Ophthalmology Therapies Market Overview

24.2. USA Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Personalized Ophthalmology Therapies Market

25.1. Canada Personalized Ophthalmology Therapies Market Overview

25.2. Canada Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Personalized Ophthalmology Therapies Market

26.1. South America Personalized Ophthalmology Therapies Market Overview

26.2. South America Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Personalized Ophthalmology Therapies Market

27.1. Brazil Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Personalized Ophthalmology Therapies Market

28.1. Middle East Personalized Ophthalmology Therapies Market Overview

28.2. Middle East Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Personalized Ophthalmology Therapies Market

29.1. Africa Personalized Ophthalmology Therapies Market Overview

29.2. Africa Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Personalized Ophthalmology Therapies Market Competitive Landscape And Company Profiles

30.1. Personalized Ophthalmology Therapies Market Competitive Landscape

30.2. Personalized Ophthalmology Therapies Market Company Profiles

30.2.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Alcon Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Genentech Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Personalized Ophthalmology Therapies Market Other Major And Innovative Companies

31.1. Bausch + Lomb Corporation

31.2. Johnson & Johnson Vision Care Inc.

31.3. Carl Zeiss Meditec AG

31.4. Santen Pharmaceutical Co. Ltd.

31.5. Ocular Therapeutix Inc.

31.6. EyePoint Pharmaceuticals Inc.

31.7. Senju Pharmaceutical Co. Ltd.

31.8. MeiraGTx Ltd.

31.9. Beacon Therapeutics

31.10. Clearside Biomedical Inc.

31.11. Adverum Biotechnologies Inc.

31.12. Ocugen Inc.

31.13. GenSight Biologics

31.14. Nanoscope Therapeutics Inc.

31.15. 4D Molecular Therapeutics Inc.

32. Global Personalized Ophthalmology Therapies Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Personalized Ophthalmology Therapies Market

34. Recent Developments In The Personalized Ophthalmology Therapies Market

35. Personalized Ophthalmology Therapies Market High Potential Countries, Segments and Strategies

35.1 Personalized Ophthalmology Therapies Market In 2029 - Countries Offering Most New Opportunities

35.2 Personalized Ophthalmology Therapies Market In 2029 - Segments Offering Most New Opportunities

35.3 Personalized Ophthalmology Therapies Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Personalized Ophthalmology Therapies Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Personalized Ophthalmology Therapies Market, Sub-Segmentation Of Cell Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Personalized Ophthalmology Therapies Market, Sub-Segmentation Of Pharmacogenomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Personalized Ophthalmology Therapies Market, Sub-Segmentation Of Targeted Drug Delivery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Personalized Ophthalmology Therapies Market, Sub-Segmentation Of Other Therapy Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Personalized Ophthalmology Therapies Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Personalized Ophthalmology Therapies Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Roche Holding AG Financial Performance

Table 80: Novartis AG Financial Performance

Table 81: Regeneron Pharmaceuticals Inc. Financial Performance

Table 82: Alcon Inc. Financial Performance

Table 83: Genentech Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Personalized Ophthalmology Therapies Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Personalized Ophthalmology Therapies Market, Sub-Segmentation Of Cell Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Personalized Ophthalmology Therapies Market, Sub-Segmentation Of Pharmacogenomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Personalized Ophthalmology Therapies Market, Sub-Segmentation Of Targeted Drug Delivery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Personalized Ophthalmology Therapies Market, Sub-Segmentation Of Other Therapy Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Personalized Ophthalmology Therapies Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Personalized Ophthalmology Therapies Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Roche Holding AG Financial Performance

Figure 80: Novartis AG Financial Performance

Figure 81: Regeneron Pharmaceuticals Inc. Financial Performance

Figure 82: Alcon Inc. Financial Performance

Figure 83: Genentech Inc. Financial Performance

Next-Gen Primary Health Care Service : Market Forecast, Transformation, and Long-Term Trajectories

Progressive Ataxia And Weakness Disorders Growth Trajectory: Key Forecasts and Strategic Insights

Prostate Cancer Nuclear Medicine Diagnostics Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Emerging Trends Redefining the Prostate Cancer Nuclear Medicine Diagnostics Market Landscape: Automated Parallel Capillary Electrophoresis Systems Transforming Protein Analysis In The Protein Chip Market

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Ophthalmic Drugs Global Market Report 2025 – By Type (Prescription Drugs, Over-The-Counter Drugs), By Class (Anti-Allergy, Anti-Inflammatory, Anti-Glaucoma, Other Classes), By Disease (Dry Eye, Eye Allergy, Glaucoma, Eye...

Anemia And Other Blood Disorder Drugs Global Market Report 2025 – By Type (Iron Deficiency Anemia, Chronic Kidney Disease Anemia, Sickle Cell Anemia, Aplastic Anemia), By Route of Administration (Oral, Injectable), By Di...

Ophthalmic Devices Global Market Report 2025 – By Type (Vision Care Devices And Equipment, Cataract Surgery Devices And Equipment, Refractive Surgery Devices And Equipment, Diagnostic And Monitoring Ophthalmic Devices An...

Ocular Inflammation Treatment Global Market Report 2025 – By Treatment Type (Immunosuppressant, Antivirals, Corticosteroids, Antibiotics, Analgesics, Monoclonal Antibodies, Antifungal, Cycloplegic), By Mode of Operation ...

Ocular Drug Delivery Global Market Report 2025 – By Technology (Implantable Ocular Drug Delivery Systems, Particulate Drug Delivery Systems, Nano-Particle Drug Delivery System, Other Technologies), By Formulation (Liposo...

Ophthalmic Medical Lasers Global Market Report 2025 – By Product (Diode Lasers, Femtosecond Lasers, Excimer Lasers Aromatherapy, ND (Yag Lasers, Other Products), By Application (Refractive Error Correction, Cataract Remo...

Ophthalmic Eye Dropper Global Market Report 2025 – By Eye Dropper (Unidose Eye Dropper, Preserved Multi-Dose Eye Dropper, Preservative-Free Multi-Dose Eye Dropper), By Drug Type (Prescription Drugs, Over-The-Counter (OTC...

Frequently Asked Questions

What is the definition of the Personalized Ophthalmology Therapies market?

How will the Personalized Ophthalmology Therapies market drivers and restraints affect the market dynamics? What forces will shape the Personalized Ophthalmology Therapies industry going forward?

The market major growth driver - Rising Prevalence Of Chronic Vision Disorders Driving The Growth Of The Market Due To Increasing Diabetes Cases And Associated Eye Complications. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Personalized Ophthalmology Therapies market?

The personalized ophthalmology therapies market size has grown rapidly in recent years. It will grow from $2.82 billion in 2024 to $3.23 billion in 2025 at a compound annual growth rate (CAGR) of 14.4%. The growth in the historic period can be attributed to increasing rates of diabetes, government initiatives, an aging population, growing demand for precision medicine in eye care, and increasing prevalence of ophthalmic diseases. The personalized ophthalmology therapies market size is expected to see rapid growth in the next few years. It will grow to $5.46 billion in 2029 at a compound annual growth rate (CAGR) of 14.0%. The growth in the forecast period can be attributed to increasing accessibility of genetic testing and molecular diagnostics, surge in cases of age-related macular degeneration, rising awareness of personalized medicine, increasing healthcare expenditure, and increasing investment in ophthalmic research. Major trends in the forecast period include strategic collaborations between biotechnology firms, research institutes, and healthcare providers, deployment of artificial intelligence and machine learning in ophthalmology, integration of genomics and digital health technologies, rapid advancements in genetic and cellular therapies, and integration of advanced technologies. For further insights on this market, request a sample here

How is the Personalized Ophthalmology Therapies market segmented?

The personalized ophthalmology therapies market covered in this report is segmented as
1) By Therapy Type: Gene Therapy, Cell Therapy, Pharmacogenomics, Targeted Drug Delivery, Other Therapy Types
2) By Indication: Age-Related Macular Degeneration, Diabetic Retinopathy, Glaucoma, Retinitis Pigmentosa, Other Indications
3) By End User: Hospitals, Specialty Clinics, Research Institutes, Other End Users Subsegments:
1) By Gene Therapy: Viral Vector-Based Gene Therapy, Non-Viral Gene Therapy, CRISPR Or Cas9-Based Gene Editing
2) By Cell Therapy: Stem Cell Therapy, Retinal Pigment Epithelial (RPE) Cell Therapy, Induced Pluripotent Stem Cell (iPSC) Therapy
3) By Pharmacogenomics: Drug Response Testing, Genetic Biomarker-Based Therapy, Personalized Drug Dosing
4) By Targeted Drug Delivery: Nanoparticle-Based Delivery, Liposomal Drug Delivery, Hydrogel-Based Delivery Systems
5) By Other Therapy Types: RNA-Based Therapy, Antisense Oligonucleotide Therapy, Peptide-Based Therapy For further insights on this market, request a sample here

Which region has the largest share of the Personalized Ophthalmology Therapies market? What are the other regions covered in the report?

North America was the largest region in the personalized ophthalmology therapies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in personalized ophthalmology therapies report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. For further insights on this market, request a sample here.

Who are the major players in the Personalized Ophthalmology Therapies market?

What are the key trends in the Personalized Ophthalmology Therapies market?

Major trends in this market include Advancements In Single-Dose Intravitreal Gene Therapies Reducing Treatment Burden And Enhancing Long-Term Efficacy For further insights on this market, request a sample here.